Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse of Patients with High-Risk MRD-Negative AML after HSCT: An Open-Label, Multicenter, Randomized Controlled Trial

Lei Gao, Yanqi Zhang, Sanbin Wang, Peiyan Kong, Yi Su, Jiong Hu, Ming Jiang, Hai Bai, Tao Lang, Jishi Wang, Li Liu, Tonghua Yang, Xiaobing Huang, Fang Liu, Shifeng Lou, Yao Liu, Cheng Zhang, Hong Liu, Li Gao, Jia LiuLidan Zhu, Qin Wen, Ting Chen, Ping Wang, Jun Rao, Min Mao, Cunbang Wang, Xianlin Duan, Le Luo, Xiangui Peng, Kaniel Cassady, Jiang F. Zhong, Xi Zhang

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)4249-4259
Number of pages11
JournalJournal of Clinical Oncology
Volume38
Issue number36
DOIs
StatePublished - Dec 20 2020
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • Recurrence
  • Prognosis
  • Humans
  • Leukemia, Myeloid, Acute/drug therapy
  • Middle Aged
  • Risk Factors
  • Child, Preschool
  • Male
  • Transplantation Conditioning/methods
  • Antineoplastic Combined Chemotherapy Protocols/pharmacology
  • Young Adult
  • Hematopoietic Stem Cell Transplantation/methods
  • Decitabine/pharmacology
  • Adolescent
  • Antimetabolites, Antineoplastic/pharmacology
  • Adult
  • Female
  • Filgrastim/pharmacology
  • Child

Cite this